Cargando…

A robust prognostic gene expression signature for early stage lung adenocarcinoma

BACKGROUND: Stage I lung adenocarcinoma is usually not treated with adjuvant chemotherapy; however, around half of these patients do not survive 5 years. Therefore, a reliable prognostic biomarker for early stage patients would be critical to identify those most likely to benefit from early addition...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krzystanek, Marcin, Moldvay, Judit, Szüts, David, Szallasi, Zoltan, Eklund, Aron Charles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4761211/ https://www.ncbi.nlm.nih.gov/pubmed/26900477 http://dx.doi.org/10.1186/s40364-016-0058-3

Ejemplares similares

A subset of lung cancer cases shows robust signs of homologous recombination deficiency associated genomic mutational signatures
por: Diossy, Miklos, et al.
Publicado: (2021)

Biasogram: Visualization of Confounding Technical Bias in Gene Expression Data
por: Krzystanek, Marcin, et al.
Publicado: (2013)

Thrombocytosis portends adverse prognostic significance in patients with stage II colorectal carcinoma
por: Guo, Tianhua, et al.
Publicado: (2014)

BRAF RNA is prognostic and widely expressed in lung adenocarcinoma
por: Dora, David, et al.
Publicado: (2023)

Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma
por: Wu, Pancheng, et al.
Publicado: (2020)

Longitudinal analysis of complete blood count parameters in advanced‐stage lung cancer patients
por: Rojko, Livia, et al.
Publicado: (2020)

The Genome of the Chicken DT40 Bursal Lymphoma Cell Line
por: Molnár, János, et al.
Publicado: (2014)

Potential Association of Cytochrome P450 Copy Number Alteration in Tumour with Chemotherapy Resistance in Lung Adenocarcinoma Patients
por: Incze, Evelyn, et al.
Publicado: (2023)

Pan-cancer analysis of genomic scar signatures associated with homologous recombination deficiency suggests novel indications for existing cancer drugs
por: Marquard, Andrea M, et al.
Publicado: (2015)

Neutrophil–lymphocyte ratio is prognostic in early stage resected small-cell lung cancer
por: Lohinai, Zoltan, et al.
Publicado: (2019)

A comprehensive survey of the mutagenic impact of common cancer cytotoxics
por: Szikriszt, Bernadett, et al.
Publicado: (2016)

Correction of technical bias in clinical microarray data improves concordance with known biological information
por: Eklund, Aron C, et al.
Publicado: (2008)

Migrating the SNP array-based homologous recombination deficiency measures to next generation sequencing data of breast cancer
por: Sztupinszki, Zsofia, et al.
Publicado: (2018)

Development and Validation of a Robust Ferroptosis-Related Prognostic Signature in Lung Adenocarcinoma
por: Zhang, Anran, et al.
Publicado: (2021)

PD-1 and PD-L1 expression in rare lung tumors
por: Gyulai, Marton, et al.
Publicado: (2023)

A Robust 8-Gene Prognostic Signature for Early-Stage Non-small Cell Lung Cancer
por: He, Ru, et al.
Publicado: (2019)

Minimising Immunohistochemical False Negative ER Classification Using a Complementary 23 Gene Expression Signature of ER Status
por: Li, Qiyuan, et al.
Publicado: (2010)

Identification of an Individualized Metabolism Prognostic Signature and Related Therapy Regimens in Early Stage Lung Adenocarcinoma
por: Hu, Junjie, et al.
Publicado: (2021)

EGFR variant allele frequency predicts EGFR-TKI efficacy in lung adenocarcinoma: a multicenter study
por: Gieszer, Balazs, et al.
Publicado: (2021)

Prognostic Fifteen-Gene Signature for Early Stage Pancreatic Ductal Adenocarcinoma
por: Chen, Dung-Tsa, et al.
Publicado: (2015)

Robust Prognostic Gene Expression Signatures in Bladder Cancer and Lung Adenocarcinoma Depend on Cell Cycle Related Genes
por: Dancik, Garrett M., et al.
Publicado: (2014)

Identification of a Novel Prognostic Signature of Genome Instability-Related LncRNAs in Early Stage Lung Adenocarcinoma
por: Peng, Bo, et al.
Publicado: (2021)

Claudin expression in pulmonary adenoid cystic carcinoma and mucoepidermoid carcinoma
por: Gyulai, Marton, et al.
Publicado: (2023)

Optimization of the BLASTN substitution matrix for prediction of non-specific DNA microarray hybridization
por: Eklund, Aron C., et al.
Publicado: (2010)

KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis
por: Lohinai, Zoltan, et al.
Publicado: (2017)

Bone-Specific Metastasis Pattern of Advanced-Stage Lung Adenocarcinoma According to the Localization of the Primary Tumor
por: Radeczky, Peter, et al.
Publicado: (2021)

TumorTracer: a method to identify the tissue of origin from the somatic mutations of a tumor specimen
por: Marquard, Andrea Marion, et al.
Publicado: (2015)

An integrated analysis of prognostic mRNA signature in early- and progressive-stage gastric adenocarcinoma
por: Hong, Xiaoling, et al.
Publicado: (2023)

Computed Tomography-Based Quantitative Texture Analysis and Gut Microbial Community Signatures Predict Survival in Non-Small Cell Lung Cancer
por: Dora, David, et al.
Publicado: (2023)

Identification of four differentially methylated genes as prognostic signatures for stage I lung adenocarcinoma
por: Luo, Wei-Ming, et al.
Publicado: (2018)

Non-Coding RNAs as Prognostic Biomarkers: A miRNA Signature Specific for Aggressive Early-Stage Lung Adenocarcinomas
por: Dama, Elisa, et al.
Publicado: (2020)

Robust Glycogene-Based Prognostic Signature for Proficient Mismatch Repair Colorectal Adenocarcinoma
por: Li, Yixi, et al.
Publicado: (2021)

An individualized immune prognostic signature in lung adenocarcinoma
por: Sun, Liangdong, et al.
Publicado: (2020)

Fast and accurate mutation detection in whole genome sequences of multiple isogenic samples with IsoMut
por: Pipek, O., et al.
Publicado: (2017)

LHX3 is an early stage and radiosensitivity prognostic biomarker in lung adenocarcinoma
por: Lin, Xin, et al.
Publicado: (2017)

Histological and prognostic data on surgically resected early-stage lung adenocarcinoma
por: Yotsukura, Masaya, et al.
Publicado: (2020)

Prognostic Significance of the Loss of Heterozygosity of KRAS in Early-Stage Lung Adenocarcinoma
por: Khadse, Anand, et al.
Publicado: (2022)

Prognostic Value and Genome Signature of m6A/m5C Regulated Genes in Early-Stage Lung Adenocarcinoma
por: Tian, Long, et al.
Publicado: (2023)

Prognostic and predictive value of radiomic signature in stage I lung adenocarcinomas following complete lobectomy
por: Nie, Wei, et al.
Publicado: (2022)

Feasibility study of in vitro drug sensitivity assay of advanced non-small cell lung adenocarcinomas
por: Papp, Emoke, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bbt69njmqc62f3qutdl18fs2k7